{"disease":{"id":"hyperphosphatemia","name":"Hyperphosphatemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"sucroferric-oxyhydroxide","indication_name":"Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ferrlecit","generic_name":"sucroferric oxyhydroxide","company_name":"Vifor Fresenius","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphate Binder [EPC]","quality_score":10,"revenue":null,"mechanism":"Ferrlecit binds to dietary phosphate in the gut, preventing its absorption into the bloodstream."},{"drug_id":"ferric-citrate","indication_name":"Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Auryxia","generic_name":"FERRIC CITRATE","company_name":"Keryx Biopharms","drug_phase":"marketed","molecular_target":"","drug_class":"ferric citrate","quality_score":10,"revenue":null,"mechanism":"Auryxia works by binding to phosphate in the gut, reducing its absorption, and also providing iron to the body."},{"drug_id":"sevelamer-carbonate","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Renvela","generic_name":"SEVELAMER CARBONATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphate Binder","quality_score":60,"revenue":null,"mechanism":"Renvela works by binding to dietary phosphate in the gut, preventing its absorption into the bloodstream."},{"drug_id":"colestilan","indication_name":"Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colestimide","generic_name":"colestilan","company_name":"Tanabe Pharma Corporation","drug_phase":"discontinued","molecular_target":"","drug_class":"colestilan","quality_score":0,"revenue":null,"mechanism":"Colestimide works by inhibiting the absorption of cholesterol and/or phosphorus in the intestines."},{"drug_id":"renvela","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Renvela","company_name":"Ardelyx","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":12,"revenue":null,"mechanism":null},{"drug_id":"calcium-acetate","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phoslo","generic_name":"CALCIUM ACETATE","company_name":"Fresenius Medcl Care","drug_phase":"marketed","molecular_target":"","drug_class":"calcium acetate","quality_score":75,"revenue":null,"mechanism":"Phoslo works by increasing calcium levels in the blood to treat conditions related to low calcium."},{"drug_id":"velphoro","indication_name":"Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Velphoro","company_name":"RWTH Aachen University","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03573089","title":"Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT01419327","title":"Fosrenol Post-marketing Surveillance for Hemodialysis in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":3267,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01578200","title":"Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2309,"lead_sponsor_name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","has_results":false},{"nct_id":"NCT00567723","title":"Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)","phase":"","overall_status":"COMPLETED","enrollment_count":2105,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT03427125","title":"A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1559,"lead_sponsor_name":"Ardelyx","has_results":true},{"nct_id":"NCT02687594","title":"Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)","phase":"","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":false},{"nct_id":"NCT06186934","title":"Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Kyowa Kirin Korea Co., Ltd.","has_results":false},{"nct_id":"NCT07030595","title":"AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":474,"lead_sponsor_name":"Alebund Pharmaceuticals","has_results":false},{"nct_id":"NCT01412398","title":"Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01955876","title":"Fosrenol Post-marketing Surveillance in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04549597","title":"Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Ardelyx","has_results":true},{"nct_id":"NCT05699239","title":"A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07285304","title":"A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05085275","title":"Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":289,"lead_sponsor_name":"USRC Kidney Research","has_results":true},{"nct_id":"NCT03644264","title":"PA21 Safety and Efficacy in Adult Chinese Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":false},{"nct_id":"NCT06933472","title":"A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":264,"lead_sponsor_name":"Alebund Pharmaceuticals","has_results":false},{"nct_id":"NCT03984760","title":"Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Panion & BF Biotech Inc.","has_results":false},{"nct_id":"NCT04456803","title":"Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":239,"lead_sponsor_name":"Sinomune Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03824587","title":"Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Ardelyx","has_results":true},{"nct_id":"NCT04922645","title":"Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"USRC Kidney Research","has_results":false},{"nct_id":"NCT04771780","title":"Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT03864458","title":"Dose-finding Study of KHK7791 in Hyperphosphatemia Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT03001011","title":"Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT03256838","title":"Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Panion & BF Biotech Inc.","has_results":false},{"nct_id":"NCT03988920","title":"A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Ardelyx","has_results":true},{"nct_id":"NCT04766398","title":"Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT04767581","title":"Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT04551300","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Shanghai Alebund Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT06712654","title":"A Study to Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatemia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":144,"lead_sponsor_name":"Alebund Pharmaceuticals","has_results":false},{"nct_id":"NCT03861247","title":"Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Chen Jing","has_results":false},{"nct_id":"NCT06745531","title":"A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06206135","title":"Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Kyowa Kirin Korea Co., Ltd.","has_results":false},{"nct_id":"NCT07285291","title":"A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05439980","title":"Improving Phosphate Control in Children With CKD","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false},{"nct_id":"NCT02688764","title":"A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":85,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":true},{"nct_id":"NCT05577507","title":"Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT03146923","title":"Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT04789876","title":"Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Taylor's University","has_results":false},{"nct_id":"NCT04256369","title":"Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT03831607","title":"A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT01696279","title":"A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06745518","title":"A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04579315","title":"Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Bo Feldt-Rasmussen","has_results":false},{"nct_id":"NCT05764590","title":"A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Alebund Pharmaceuticals","has_results":false},{"nct_id":"NCT03079869","title":"Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT04766385","title":"Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT06664125","title":"Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT04440696","title":"To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Grand Life Science (Liaoning) Co., Ltd.","has_results":false},{"nct_id":"NCT03864445","title":"Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT05897502","title":"Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Liu, Liu-Yin","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}